UniProt ID | ETV5_HUMAN | |
---|---|---|
UniProt AC | P41161 | |
Protein Name | ETS translocation variant 5 | |
Gene Name | ETV5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 510 | |
Subcellular Localization | Nucleus. | |
Protein Description | Binds to DNA sequences containing the consensus nucleotide core sequence 5'-GGAA.-3'.. | |
Protein Sequence | MDGFYDQQVPFMVPGKSRSEECRGRPVIDRKRKFLDTDLAHDSEELFQDLSQLQEAWLAEAQVPDDEQFVPDFQSDNLVLHAPPPTKIKRELHSPSSELSSCSHEQALGANYGEKCLYNYCAYDRKPPSGFKPLTPPTTPLSPTHQNPLFPPPQATLPTSGHAPAAGPVQGVGPAPAPHSLPEPGPQQQTFAVPRPPHQPLQMPKMMPENQYPSEQRFQRQLSEPCHPFPPQPGVPGDNRPSYHRQMSEPIVPAAPPPPQGFKQEYHDPLYEHGVPGMPGPPAHGFQSPMGIKQEPRDYCVDSEVPNCQSSYMRGGYFSSSHEGFSYEKDPRLYFDDTCVVPERLEGKVKQEPTMYREGPPYQRRGSLQLWQFLVTLLDDPANAHFIAWTGRGMEFKLIEPEEVARRWGIQKNRPAMNYDKLSRSLRYYYEKGIMQKVAGERYVYKFVCDPDALFSMAFPDNQRPFLKAESECHLSEEDTLPLTHFEDSPAYLLDMDRCSSLPYAEGFAY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MDGFYDQQVPFM ---CCCCCCCCCCCC | 20.55 | 24043423 | |
17 | Phosphorylation | PFMVPGKSRSEECRG CCCCCCCCCCHHHCC | 47.13 | 24043423 | |
19 | Phosphorylation | MVPGKSRSEECRGRP CCCCCCCCHHHCCCC | 44.85 | 24043423 | |
89 | Sumoylation | APPPTKIKRELHSPS CCCCCCCCHHHCCCC | 41.18 | - | |
89 | Sumoylation | APPPTKIKRELHSPS CCCCCCCCHHHCCCC | 41.18 | - | |
94 | Phosphorylation | KIKRELHSPSSELSS CCCHHHCCCCHHHHH | 38.82 | 23401153 | |
96 | Phosphorylation | KRELHSPSSELSSCS CHHHCCCCHHHHHCC | 39.19 | 25850435 | |
97 | Phosphorylation | RELHSPSSELSSCSH HHHCCCCHHHHHCCH | 46.04 | 25850435 | |
100 | Phosphorylation | HSPSSELSSCSHEQA CCCCHHHHHCCHHHH | 25.83 | 25850435 | |
101 | Phosphorylation | SPSSELSSCSHEQAL CCCHHHHHCCHHHHH | 32.06 | 25850435 | |
103 | Phosphorylation | SSELSSCSHEQALGA CHHHHHCCHHHHHCC | 31.82 | 27251275 | |
112 | Phosphorylation | EQALGANYGEKCLYN HHHHCCCCCCCCCCH | 26.57 | 27251275 | |
118 | Phosphorylation | NYGEKCLYNYCAYDR CCCCCCCCHHHCCCC | 17.35 | 23401153 | |
120 | Phosphorylation | GEKCLYNYCAYDRKP CCCCCCHHHCCCCCC | 2.49 | 23401153 | |
123 | Phosphorylation | CLYNYCAYDRKPPSG CCCHHHCCCCCCCCC | 16.84 | 23401153 | |
142 | Phosphorylation | TPPTTPLSPTHQNPL CCCCCCCCCCCCCCC | 29.02 | 25690035 | |
144 | Phosphorylation | PTTPLSPTHQNPLFP CCCCCCCCCCCCCCC | 32.49 | 25690035 | |
223 | Phosphorylation | QRFQRQLSEPCHPFP HHHHHHHCCCCCCCC | 31.02 | 29116813 | |
248 | Phosphorylation | PSYHRQMSEPIVPAA CCCCCCCCCCCCCCC | 31.70 | 28112733 | |
263 | Sumoylation | PPPPQGFKQEYHDPL CCCCCCCCHHCCCCH | 49.39 | - | |
263 | Sumoylation | PPPPQGFKQEYHDPL CCCCCCCCHHCCCCH | 49.39 | - | |
293 | Sumoylation | FQSPMGIKQEPRDYC CCCCCCCCCCCCCCC | 42.77 | - | |
293 | Sumoylation | FQSPMGIKQEPRDYC CCCCCCCCCCCCCCC | 42.77 | - | |
299 | Phosphorylation | IKQEPRDYCVDSEVP CCCCCCCCCCCCCCC | 8.82 | 24043423 | |
303 | Phosphorylation | PRDYCVDSEVPNCQS CCCCCCCCCCCCCCC | 21.79 | 24043423 | |
310 | Phosphorylation | SEVPNCQSSYMRGGY CCCCCCCCCHHCCCC | 26.15 | 24043423 | |
311 | Phosphorylation | EVPNCQSSYMRGGYF CCCCCCCCHHCCCCC | 9.32 | 24043423 | |
312 | Phosphorylation | VPNCQSSYMRGGYFS CCCCCCCHHCCCCCC | 8.97 | 24043423 | |
329 | Ubiquitination | HEGFSYEKDPRLYFD CCCCCCCCCCCEEEC | 65.87 | 29967540 | |
350 | Sumoylation | ERLEGKVKQEPTMYR HHHCCCCCCCCCCCC | 53.05 | 28112733 | |
350 | Sumoylation | ERLEGKVKQEPTMYR HHHCCCCCCCCCCCC | 53.05 | - | |
367 | Phosphorylation | PPYQRRGSLQLWQFL CCCCCCCHHHHHHHH | 15.90 | 22817900 | |
376 | Phosphorylation | QLWQFLVTLLDDPAN HHHHHHHHHHCCHHH | 24.61 | 24043423 | |
390 | Phosphorylation | NAHFIAWTGRGMEFK HCCEEEEECCCCEEE | 14.15 | 24043423 | |
419 | Phosphorylation | KNRPAMNYDKLSRSL CCCCCCCHHHHHHHH | 11.02 | 26657352 | |
423 | Phosphorylation | AMNYDKLSRSLRYYY CCCHHHHHHHHHHHH | 26.09 | 26657352 | |
425 | Phosphorylation | NYDKLSRSLRYYYEK CHHHHHHHHHHHHHH | 17.52 | 25954137 | |
443 | Phosphorylation | QKVAGERYVYKFVCD HHHCCCCEEEEEEEC | 12.11 | - | |
468 | Sumoylation | DNQRPFLKAESECHL CCCCCCCHHCCCCCC | 50.95 | - | |
468 | Sumoylation | DNQRPFLKAESECHL CCCCCCCHHCCCCCC | 50.95 | - | |
476 | Phosphorylation | AESECHLSEEDTLPL HCCCCCCCCCCCCCC | 18.44 | 30624053 | |
480 | Phosphorylation | CHLSEEDTLPLTHFE CCCCCCCCCCCCCCC | 33.29 | 30624053 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
367 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
367 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
367 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | COP1 | Q8NHY2 | PMID:20062082 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ETV5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETV5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RFWD2_HUMAN | RFWD2 | physical | 20062082 | |
A4_HUMAN | APP | physical | 21832049 | |
SE6L2_HUMAN | SEZ6L2 | physical | 21988832 | |
S22A2_HUMAN | SLC22A2 | physical | 21988832 | |
HXD9_HUMAN | HOXD9 | physical | 21988832 | |
STK40_HUMAN | STK40 | physical | 26186194 | |
MYH14_HUMAN | MYH14 | physical | 26186194 | |
RFWD2_HUMAN | RFWD2 | physical | 26186194 | |
UB2E3_HUMAN | UBE2E3 | physical | 26186194 | |
DET1_HUMAN | DET1 | physical | 26186194 | |
DET1_HUMAN | DET1 | physical | 28514442 | |
RFWD2_HUMAN | RFWD2 | physical | 28514442 | |
STK40_HUMAN | STK40 | physical | 28514442 | |
UB2E3_HUMAN | UBE2E3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...